Assuntos
Humanos , Masculino , Lactente , Doença de Depósito de Glicogênio/complicações , Doença de Depósito de Glicogênio/diagnóstico , Doença de Depósito de Glicogênio/tratamento farmacológico , Corticosteroides/uso terapêutico , Doenças Pulmonares Intersticiais/complicações , Doenças Pulmonares Intersticiais/diagnóstico , Doenças Pulmonares Intersticiais/tratamento farmacológico , Cardiopatias Congênitas/complicações , Cardiopatias Congênitas/diagnósticoRESUMO
The use of mask and face shield has been established as one of the main preventive measures for the control of COVID 19 spread. In Mexico, as well as in other regions of the world, 3D printing has been employed for the design and production of masks and face shields as personal protective equipment (PPE). These models have been fabricated mainly by the makers, industries, and university communities; therefore, it is necessary to analyze the feasibility of the 3D printed PPE to understand its advantages and limitations. In this work, some characteristics of masks and face shields fabricated by additive manufacturing were studied to explore their viability as protection against flow fluids similar to human sneeze. In the present paper, the PPE was designed, and 3D printed utilizing three types of polylactic acid (PLA) as base material. The morphology and the surface elemental analyses of sectioned samples were analyzed by scanning electron microscopy (SEM) and energy dispersion x-ray spectroscopy (EDS). Showing spacing between printed layers, porous areas, and dispersed copper particles. On the other hand, a computational fluid dynamics (CFD) simulation was carried out, the results demonstrated the importance of using PPE for protection of a possible exposure to a "contaminated" aerosol and human sneeze. Based on the abovementioned results, it is possible to consider the commercial PLA as suitable material for the manufacturing of PPE due to its capability to be disinfected employing isopropanol, ethanol, or commercial disinfectants.
RESUMO
BACKGROUND AND OBJECTIVE: Periodontitis may alter the systemic condition in patients with diabetes and hence interfere with glycemic control. The objective of this study was to determine the quantifiable changes in glycated hemoglobin (HbA1C) after periodontal non-surgical therapy plus azithromycin in a mixed population of patients with poorly controlled diabetes. MATERIALS AND METHODS: One hundred and five patients were randomized to receive non-surgical therapy plus azythromycin (AZ-Sca =33), non-surgical therapy plus placebo (PB-Sca = 37) and supragingival prophylaxis plus azithromycin (AZ-Pro = 35). Glycated hemoglobin, glycemia and periodontal parameters were measured at baseline, 3, 6 and 9 mo after treatment. RESULTS: Periodontal parameters were improved in the AZ-Sca and PB-Sca groups as compared to the AZ-Pro group. A greater reduction in probing depth was observed in the AZ-Sca as compared to the PB-Sca group. Improvement in clinical attachment level was similar between AZ-Sca and PB-Sca groups. A reduction from 8.0% to 7.2% (∆0.8%; p < 0.05) in HbA1C was observed in the AZ-Sca at 9 mo as compared to the PB-Sca group in which the reduction was from 7.9% to 7.6% (∆0.3%). There was no decrease in HbA1C in the AZ-Pro group over time. Mean glycemia values decreased from 195 mg/dL to 159.2 mg/dL (∆35.8 mg/dL; p < 0.05) in the AZ-Sca group whereas a decrease from 194 mg/dL to 174.8 mg/dL (∆19.2 mg/dL) in the PB-Sca group at 9 mo was observed. There were no differences between the AZ-Sca and PB-Sca groups for glycemic parameters. No improvement in glycemic values in the AZ-Pro group was observed. CONCLUSIONS: A modest improvement in glycemic control was detected with a trend towards the use of non-surgical therapy plus AZ as compared to the placebo.
Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Glicemia/análise , Diabetes Mellitus Tipo 1/prevenção & controle , Diabetes Mellitus Tipo 2/prevenção & controle , Hemoglobinas Glicadas/análise , Desbridamento Periodontal/métodos , Terapia Combinada , Profilaxia Dentária/métodos , Raspagem Dentária/métodos , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 2/sangue , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Perda da Inserção Periodontal/terapia , Índice Periodontal , Bolsa Periodontal/terapia , Periodontite/terapia , PlacebosRESUMO
Presentamos un etudio acerca de las condiciones de trabajo y de salud de una veterinaria embarazada, trabajadora de un matadero que acude a nuestro servicio por su preocupación ante la posibilidad de contraer alguna infección que pueda perjudicarla a ella o al feto (AU)
We report the working conditions and healht surveillance study of a pregnant veterinary, who came to our Labour Risk Prevention Service because she worked in a slaughterhouse, is pregnant, and is afraid of the eventual transmission of a communicable disease that might endanger her or the foetus (AU)
Assuntos
Humanos , Feminino , Gravidez , Adulto , Exposição Ocupacional/análise , Matadouros , Complicações na Gravidez/prevenção & controle , 16360RESUMO
Inflammation is necessary for survival, but it is also an important cause of human morbidity and mortality, as exemplified by sepsis. During inflammation, cells of the innate immune system are recruited and activated in response to infection, trauma or injury. These cells are activated through receptors, such as Toll-like receptors (TLRs), which recognize microbial ligands such as lipopolysaccharide (LPS). Triggering receptor expressed on myeloid cells (TREM)-1 amplifies the inflammatory response initiated by TLRs, and its expression on the surface of monocytes increases in the presence of TLR ligands. Here we have shown that in monocytes TREM-1 mRNA levels, measured by reverse transcription-polymerase chain reaction (RT-PCR), remained unchanged and TREM-1 protein levels, measured by flow cytometry, increased, indicating that LPS increases TREM-1 expression by a post-transcriptional mechanism. We also showed that TREM-1/Fc fusion protein decreased the ability of the sera of some patients with sepsis to activate monocytes, indicating that the TREM-1 ligand, whose identity is unknown, may be present in the sera of some of these patients. We describe a mechanism for the regulation of TREM-1 expression on monocytes and the possible presence of its ligand in serum; these findings help to explain the contribution of TREM-1 during systemic inflammation.
Assuntos
Glicoproteínas de Membrana/análise , Glicoproteínas de Membrana/sangue , Monócitos/metabolismo , Processamento Pós-Transcricional do RNA , Receptores Imunológicos/análise , Receptores Imunológicos/sangue , Sepse/imunologia , Adulto , Técnicas de Cultura de Células , Distribuição de Qui-Quadrado , Feminino , Citometria de Fluxo/métodos , Humanos , Interleucina-10/imunologia , Lipopolissacarídeos/farmacologia , Ativação Linfocitária , Masculino , Glicoproteínas de Membrana/genética , Pessoa de Meia-Idade , RNA Mensageiro/análise , Receptores Imunológicos/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sepse/sangue , Estatísticas não Paramétricas , Receptor Gatilho 1 Expresso em Células Mieloides , Fator de Necrose Tumoral alfa/imunologiaRESUMO
El trabajo que presentamos describe la incorporación de un celador de quirófano a su puesto de trabajo tras sufrir un infarto que dio lugar a una baja laboral de 18 meses de duración. En su puesto de trabajo se realiza manipulación de cargas y el trabajador teme que esto afecte a su salud. Se realiza análisis ergonómico de su puesto de trabajo, valorando sobre todo la carga física dinámica para comprobar si se ajusta a las recomendaciones que realiza el cardiólogo (AU)